awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34486116-302DA42D-EE9E-4E7B-BCDC-515A7D12B0FC
Q34486116-302DA42D-EE9E-4E7B-BCDC-515A7D12B0FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34486116-302DA42D-EE9E-4E7B-BCDC-515A7D12B0FC
The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.
P2860
Q34486116-302DA42D-EE9E-4E7B-BCDC-515A7D12B0FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34486116-302DA42D-EE9E-4E7B-BCDC-515A7D12B0FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3bdca3c992bfd44c286c0aa0c979e8575524738
P2860
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.